Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy

Journal of Diabetes and its Complications

Volumn 22, Issue 5, 2008, Pages 331-338

  Ezzidi, Intissar ^a   Mtiraoui, Nabil ^a   Mohamed, Manel Ben Hadj ^a   Mahjoub, Touhami ^a   Kacem, Maha ^b   Almawi, Wassim Y ^c  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b Nephrology and Internal Medicine Service EPS F Bourguiba   (Tunisia)

^c ARABIAN GULF UNIVERSITY   (Bahrain)

Author keywords

Diabetes; Nitric oxide; Polymorphism

Indexed keywords

CREATININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; EXON; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLOMERULUS FILTRATION RATE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MUTANT; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL SIGNIFICANCE;

AGED; ASPARTIC ACID; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTAMIC ACID; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC;

EID: 50049101159     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2007.11.011     Document Type: Article

References (44)

1. Agius E., Attard G., Shakespeare L., Clark P., Vidya M.A., Hattersley A.T., and Fava S. Familial factors in diabetic nephropathy: An offspring study. Diabetic Medicine 23 (2006) 331-334
2. Asakimori Y., Yorioka N., Taniguchi Y., Ito T., Ogata S., Kyuden Y., and Kohno N. T(-786)→C polymorphism of the endothelial nitric oxide synthase gene influences the progression of renal disease. Nephron 91 (2002) 747-751
3. Brouet A., Sonveaux P., Dessy C., Balligand J.L., and Feron O. Hsp90 ensures the transition from the early Ca2+-dependent to the late phosphorylation-dependent activation of the endothelial nitric-oxide synthase in vascular endothelial growth factor-exposed endothelial cells. Journal of Biological Chemistry 276 (2001) 32663-32669
4. Chen W., Srinivasan S.R., Li S., Boerwinkle E., and Berenson G.S. Gender-specific influence of NO synthase gene on blood pressure since childhood: The Bogalusa Heart Study. Hypertension 44 (2004) 668-673
5. de Syllos R.W., Sandrim V.C., Lisboa H.R., Tres G.S., and Tanus-Santos J.E. Endothelial nitric oxide synthase genotype and haplotype are not associated with diabetic retinopathy in diabetes type 2 patients. Nitric Oxide 15 (2006) 417-422
6. Fairchild T.A., Fulton D., Fontana J.T., Gratton J.P., McCabe T.J., and Sessa W.C. Acidic hydrolysis as a mechanism for the cleavage of the Glu(298)→Asp variant of human endothelial nitric-oxide synthase. Journal of Biological Chemistry 276 (2001) 26674-26679
7. Fatini C., Sofi F., Gori A.M., Sticchi E., Marcucci R., Lenti M., Casini A., Surrenti C., Abbate R., and Gensini G.F. Endothelial nitric oxide synthase -786T>C, but not 894G>T and 4a4b, polymorphism influences plasma homocysteine concentrations in persons with normal vitamin status. Clinical Chemistry 51 (2005) 1159-1164
8. Franks P.W., Luan J., Barroso I., Brage S., Gonzalez Sanchez J.L., Ekelund U., Rios M.S., Schafer A.J., O'Rahilly S., and Wareham N.J. Variation in the eNOS gene modifies the association between total energy expenditure and glucose intolerance. Diabetes 54 (2005) 2795-2801
9. Fujita H., Narita T., Meguro H., Ishii T., Hanyu O., Suzuki K., Kamoi K., and Ito S. Lack of association between an ecNOS gene polymorphism and diabetic nephropathy in type 2 diabetic patients with proliferative diabetic retinopathy. Hormone and Metabolic Research 32 (2000) 80-83
10. Giles T.D. Aspects of nitric oxide in health and disease: A focus on hypertension and cardiovascular disease. Journal of Clinical Hypertension 8 (2006) 2-16
11. Granath B., Taylor R.R., van Bockxmeer F.M., and Mamotte C.D. Lack of evidence for association between endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in the Australian Caucasian population. Journal of Cardiovascular Risk 8 (2001) 235-241
12. Hassan A., Gormley K., O'Sullivan M., Knight J., Sham P., Vallance P., Bamford J., and Markus H. Endothelial nitric oxide gene haplotypes and risk of cerebral small-vessel disease. Stroke 35 (2004) 654-659
13. Hink U., Li H., Mollnau H., Oelze M., Matheis E., Hartmann M., Skatchkov M., Thaiss F., Stahl R.A., Warnholtz A., Meinertz T., Griendling K., Harrison D.G., Forstermann U., and Munzel T. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circulation Research 88 (2001) E14-E22
14. Jaramillo P.C., Muñoz M.A., Lanas M.C., Lanas Z.F., and Salazar L.A. Endothelial nitric oxide synthase G894T gene polymorphism in Chilean subjects with coronary artery disease and controls. Clinica Chimica Acta 371 (2006) 102-106
15. Kawagishi T., Matsuyoshi M., Emoto M., Taniwaki H., Kanda H., Okuno Y., Inaba M., Ishimura E., Nishizawa Y., and Morii H. Impaired endothelium-dependent vascular responses of retinal and intrarenal arteries in patients with type 2 diabetes. Arteriosclerosis, Thrombosis, and Vascular Biology 19 (1999) 2509-2516
16. Kishimoto T., Misawa Y., Kaetu A., Nagai M., Osaki Y., Okamoto M., Yoshida S., Kurosawa Y., and Fukumoto S. eNOS Glu298Asp polymorphism and hypertension in a cohort study in Japanese. Preventive Medicine 39 (2004) 927-931
17. Komatsu M., Kawagishi T., Emoto M., Shoji T., Yamada A., Sato K., Hosoi M., and Nishizawa Y. ecNOS gene polymorphism is associated with endothelium-dependent vasodilation in Type 2 diabetes. American Journal of Physiology. Heart and Circulatory Physiology 283 (2002) H557-H561
18. Liu Y., Burdon K.P., Langefeld C.D., Beck S.R., Wagenknecht L.E., Rich S.S., Bowden D.W., and Freedman B.I. -786T>C polymorphism of the endothelial nitric oxide synthase gene is associated with albuminuria in the diabetes heart study. Journal of the American Society of Nephrology 16 (2005) 1085-1090
19. Malhotra S., Poole J., Davis H., Dong Y., Pollock J., Snieder H., and Treiber F. Effects of NOS3 Glu298Asp polymorphism on hemodynamic reactivity to stress: Influences of ethnicity and obesity. Hypertension 44 (2004) 866-871
20. Marsden P.A., Heng H.H., Scherer S.W., Stewart R.J., Hall A.V., Shi X.M., Tsui L.C., and Schappert K.T. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. Journal of Biological Chemistry 268 (1993) 17478-17488
21. Metzger I.F., Souza-Costa D.C., Marroni A.S., Nagassaki S., Desta Z., Flockhart D.A., and Tanus-Santos J.E. Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men. Pharmacogenet Genomics 15 (2005) 565-570
22. Mollsten A., Wessman M., Svensson M., Forsblom C., Parkkonen M., Brismar K., Groop P.H., and Dahlquist G. Glu298Asp and NOS4ab polymorphisms in diabetic nephropathy. Annals of Medicine 38 (2006) 522-528
23. Moncada S., and Higgs E.A. The discovery of nitric oxide and its role in vascular biology. British Journal of Pharmacology 147 (2006) S193-S201
24. Nagase S., Suzuki H., Wang Y., Kikuchi S., Hirayama A., and Ueda A. Association of ecNOS gene polymorphisms with end stage renal diseases. Molecular and Cellular Biochemistry 244 (2003) 113-118
25. Nakayama M., Yasue H., Yoshimura M., Shimasaki Y., Kugiyama K., Ogawa H., Motoyama T., Saito Y., Ogawa Y., Miyamoto Y., and Nakao K. T-786→C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99 (1999) 2864-2870
26. Neugebauer S., Baba T., and Watanabe T. Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. Diabetes 49 (2000) 500-503
27. Noiri E., Satoh H., Taguchi J., Brodsky S.V., Nakao A., Ogawa Y., Nishijima S., Yokomizo T., Tokunaga K., and Fujita T. Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension 40 (2002) 535-540
28. Pulkkinen A., Viitanen L., Kareinen A., Lehto S., Vauhkonen I., and Laakso M. Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with elevated blood pressure in type 2 diabetic patients with coronary heart disease. Journal of Molecular Medicine 78 (2000) 372-379
29. Rios D.L., D'Onofrio L.O., Souza J.K., Queiroz A.M., Raduy-Maron L., Silva-Neto N., Carvalho H.G., Santos-Filho A., and Galvão-Castro B. Smoking-dependent and haplotype-specific effects of endothelial nitric oxide synthase gene polymorphisms on angiographically assessed coronary artery disease in Caucasian- and African-Brazilians. Atherosclerosis 193 (2007) 135-141
30. Rossi G.P., Taddei S., Virdis A., Cavallin M., Ghiadoni L., Favilla S., Versari D., Sudano I., Pessina A.C., and Salvetti A. The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients. Journal of the American College of Cardiology 41 (2003) 938-945
31. Salimi S., Firoozrai M., Nourmohammadi I., Shabani M., and Mohebbi A. Endothelial nitric oxide synthase gene intron4 VNTR polymorphism in patients with coronary artery disease in Iran. Indian Journal of Medical Research 124 (2006) 683-688
32. Sandrim V.C., de Syllos R.W., Lisboa H.R., Tres G.S., and Tanus-Santos J.E. Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus. Atherosclerosis 189 (2006) 241-246
33. Schneider M.P., Erdmann J., Delles C., Fleck E., Regitz-Zagrosek V., and Schmieder R.E. Functional gene testing of the Glu298Asp polymorphism of the endothelial NO synthase. Journal of Hypertension 18 (2000) 1767-1773
34. Shin Shin Y., Baek S.H., Chang K.Y., Park C.W., Yang C.W., Jin D.C., Kim Y.S., Chang Y.S., and Bang B.K. Relations between eNOS Glu298Asp polymorphism and progression of diabetic nephropathy. Diabetes Research and Clinical Practice 65 (2004) 257-265
35. Srivastava K., Biswas U.K., Narang R., Varghese J.J., and Das N. Prevalence of eNOS Glu298Asp polymorphism in healthy volunteers from a region of Northern India. Community Genetics 8 (2005) 180-183
36. Tanus-Santos J.E., Desai M., and Flockhart D.A. Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 11 (2001) 719-725
37. Taverna M.J., Sola A., Guyot-Argenton C., Guyot-Argenton N., Bruzzo F., and Chevalier A. eNOS4 polymorphism of the endothelial nitric oxide synthase predicts risk for severe diabetic retinopathy. Diabetic Medicine 19 (2002) 240-245
38. Tesauro M., Thompson W.C., Rogliani P., Qi L., Chaudhary P.P., and Moss J. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: Cleavage of proteins with aspartate vs. glutamate at position 298. Proceedings of the National Academy of Sciences of the United States of America 97 (2000) 2832-2835
39. Wang J., Dudley D., and Wang X.L. Haplotype specific effects on endothelial NO synthase promoter efficiency: Modifiable by cigarette smoking. Arteriosclerosis, Thrombosis, and Vascular Biology 22 (2002) e1-e4
40. Wang Y., and Marsden P.A. Nitric oxide synthases: Biochemical and molecular regulation. Curr Opin Nephrol Hypertens 4 (1995) 12-22
41. Weekers L., Hadjadj S., Belloum R., Gallois Y., Bouhanick B., and Marre M. Lack of contribution of two endothelial nitric oxide synthase (eNOS) gene polymorphisms to diabetic nephropathy in type 1 diabetes. Diabetologia 42 (1999) A266
42. Zanchi A., Moczulski D.K., Hanna L.S., Hanna M., Warram J.H., and Krolewski A.S. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney International 57 (2000) 405-513
43. Zhang C., Lopez-Ridaura R., Hunter D.J., Rifai N., and Hu F.B. Common variants of the endothelial nitric oxide synthase gene and the risk of coronary heart disease among U.S. diabetic men. Diabetes 55 (2006) 2140-2147
44. Zhao Q., Su S.Y., Chen S.F., Li B., and Gu D.F. Association study of the endothelial nitric oxide synthase gene polymorphisms with essential hypertension in northern Han Chinese. Chinise Medical Journal 119 (2006) 1065-1071